MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells

FEBS Letters

Volumn 412, Issue 1, 1997, Pages 201-206

  Kim, Hwan Mook ^a   Oh, Goo Taeg ^a   Hong, Dong Ho ^a   Kim, Moon Soon ^a   Kang, Jong Seong ^b   Park, Sun Mi ^a   Han, Sang Bae ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Efflux; Influx; KB 3 1; KB V1; MCF7; MCF7 ADR; MDR gene expression

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; RHODAMINE 123; VERAPAMIL; VINBLASTINE;

ARTICLE; CELL LEVEL; CELL STRAIN KB; CELL STRAIN MCF 7; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; CALCIUM CHANNEL BLOCKERS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; P-GLYCOPROTEIN; PHENOTYPE; RNA, MESSENGER; TUMOR CELLS, CULTURED; VERAPAMIL; VINBLASTINE;

EID: 0030811180     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00777-1     Document Type: Article

References (19)

1. Mankhetkorn, S., Dubru, F., Hesschenbrouck, J., Fiallo, M. and Garnier-Suillerot, X. (1996) Mol. Pharmacol. 49, 532-539.
2. Dolci, E.D., Abramson, R., Xuan, Y., Siegfried, J., Yuenger, K.A., Yassa, D.S. and Tritton, T.R. (1993) Int. J. Cancer 54, 302-308.
3. Chao, C.C. (1995) FEBS Lett. 373, 285-290.
4. Schuurhuis, G.J., van-Heijningen, T.H., Cervantes, A., Pinedo, H.M., de-Lange, J.H., Keizer, H.G., Broxterman, H.J., Baak, J.P. and Lankelma, J. (1993) Br. J. Cancer 68, 898-908.
5. Sumizawa, T., Chuman, Y., Sakamoto, H., Iemura, K., Almquist, K.C., Deeley, R.G., Cole, S.P. and Akiyama, S. (1994) Cell Mol. Genet. 20, 423-435.
6. Noonan, K.E., Beck, C., Holzmayer, T.A., Chin, J.E., Wunder, J.S., Andrulis, I.L., Gazdar, A.F., Willman, C.L., Griffith, B., Von Hoff, D.D. and Roninson, I.B. (1990) Proc. Natl. Acad. Sci. USA 87, 7160-7164.
7. Wu, L., Smythe, A.M., Stinson, S.F., Mullendore, L.A., Monks, A., Scudiero, D.A., Paull, K.D., Koutsoukos, A.D., Rubinstein, L.V., Boyd, M.R. and Shoemaker, R.H. (1992) Cancer Res. 52, 3029-3034.
8. Chen, C.J., Chin, J.E., Ueda, K., Clark, D.P., Pastan, I., Gottesman, M.M. and Roninson, I.B. (1986) Cell 47, 381-389.
9. Chu, J.L., Drappa, J., Parnassa, A. and Elkon, K.B. (1993) J. Exp. Med. 178, 723-730.
10. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahan, J., Vistica, D., Warren, J.T., Bokesch, H., Kenny, S. and Boyd, M.R. (1990) J. Natl. Cancer Inst. 82, 1107-1112.
11. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Goodrich, M.G., Campbell, H., Mayo, J. and Boyd, M. (1991) J. Natl. Cancer Inst. 83, 757-766.
12. Chieli, E., Rugiu, E.S., Cervelli, F., Paolicchi, A. and Tongiani, R. (1993) Cell Biol. Toxicol. 9, 235-242.
13. Kato, S., Nishimura, J., Yufu, Y., Ideguchi, H., Umemura, T. and Nawata, H. (1992) FEBS Lett. 308, 175-178.
14. Crouch, S.P., Kozlowski, R., Slater, K.J. and Fletcher, J. (1993) J. Immunol. Methods 160, (1) 81-88.
15. Chiang, C.D., Song, E.J., Yang, V.C. and Chao, C.C. (1994) Biochem. J. 301, 759-764.
16. Mestdagh, N., Vandewalle, B., Hornez, L. and Henichart, J.P. (1994) Biochem. Pharmacol. 48, 709-716.
17. Blobe, G.C., Sachs, C.W., Khan, W.A., Fabbro, D., Stabel, S., Wetsel, W.C., Obeid, L.M., Fine, R.L. and Hannun, Y.A. (1993) J. Biol. Chem. 268, 658-664.
18. Yu, G., Ahmad, S., Aquino, A., Fairchild, C.R., Trepel, J.B., Ohno, S., Suzuki, K., Tsuruo, T., Cowan, K.H. and Glazer, R.I. (1991) Cancer Commun. 3, 181-189.
19. Schneider, E., Horton, J.K., Yang, C.-H., Nakagawa, M. and Cowan, K.H. (1994) Cancer Res. 54, 152-158.